NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
University Hospital, Lille
Delfi Diagnostics Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Galvanize Therapeutics, Inc.
Medipol University
University Hospital Padova
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
Thomas Jefferson University
Revolution Medicines, Inc.